← Open Payments lookup

DENYSE GALLAGHER: Open Payments

NPI 1588075055 · SOMERS POINT, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,781 in 89 payments from 25 companies in 2025. Trend: 2023 $1,472 · 2024 $2,143 · 2025 $1,781

Food & beverage: $1,781
CompanyPaymentsAmount
Insulet Corporation13$353
Abbott Laboratories18$178
Novo Nordisk Inc9$140
Madrigal Pharmaceuticals5$116
Xeris Pharmaceuticals, Inc.2$114
Bayer Healthcare Pharmaceuticals Inc.4$103
Tandem Diabetes Care, Inc.3$101
Lilly USA, LLC4$69
TOLMAR, INC.4$66
BETA BIONICS, INC.3$64

Products named: Omnipod, FREESTYLE LIBRE 3, REZDIFFRA, Kerendia, t:slim X2 Insulin Pump with Control-IQ, GVOKE HYPOPEN, Ozempic, JATENZO.

Industry payments across NJ — which companies pay providers there.